Non-cancer risks among female breast cancer survivors: a matched cohort study in Japan
Authors:
Open Access
- 23 March 2025
- journal article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 56, 101519
Abstract
No abstract availableKeywords
Funding Information
- Public Interest Incorporated Foundation Pfizer Health Research Foundation
This publication has 31 references indexed in Scilit:
- Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer RegistryBreast Cancer, 2024
- Validation studies of Japanese administrative health care data: A scoping reviewPharmacoepidemiology and Drug Safety, 2023
- Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncologyCurrent Oncology Reports, 2022
- Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005–2018Drug Safety, 2020
- Time‐dependent risk of depression, anxiety, and stress‐related disorders in patients with invasive and in situ breast cancerInternational Journal of Cancer, 2016
- Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort studyBreast Cancer Research and Treatment, 2014
- Incidence and risk of mood disorders in patients with breast cancers in Taiwan: a nationwide population‐based studyPsycho-Oncology, 2013
- Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?Cancer Treatment Reviews, 2012
- Imputing missing covariate values for the Cox modelStatistics in Medicine, 2009
- Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine TherapyArchives of General Psychiatry, 2008